• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)

    2/14/23 2:40:05 PM ET
    $ISO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $ISO alert in real time by email
    SC 13G/A 1 tm236799d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

      

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

    IsoPlexis Corporation


    (Name of Issuer)

     

    Common Stock, par value $0.001 per share


    (Title of Class of Securities)

     465005106


    (CUSIP Number)

     

    December 31, 2022


    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨  Rule 13d-1(b)

    ¨ Rule 13d-1(c)   

    x Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      Spring Mountain Capital G.P., LLC; I.R.S. Identification Number: 13-4182080
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       PN
                             

     

     

     

     

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      SMC Growth Capital II GP, LLC; I.R.S. Identification Number: 47-0961259
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    PN
                             

     

     

     

     

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      SMC Growth Capital Partners II, LP; I.R.S. Identification Number: 46-5766365
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    PN
                             

      

     

     

     

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      SMC Private Equity Holdings GP, LLC; I.R.S. Identification Number: 46-2847422
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    PN
                             

      

     

     

     

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      SMC Private Equity Holdings, LP; I.R.S. Identification Number: 46-2836477
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    PN
                             

      

     

     

     

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      SMC Holdings II G.P., LLC; I.R.S. Identification Number: 27-3065787
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    PN
                             

       

     

     

      

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      SMC Holdings II, LP; I.R.S. Identification Number: 27-3065911
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      Delaware 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
    PN
                             

     

     

     

      

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      Gregory P. Ho
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      United States 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       IN
                             

     

     

      

     CUSIP
    NO.
    465005106            
     1          
      NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
      John L. Steffens
    2    
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
      (a)   x
      (b)   ¨
    3    
      SEC USE ONLY
       
    4    
      CITIZENSHIP OR PLACE OF ORGANIZATION
      United States 
    NUMBER OF SHARES
    BENEFICIALLY  OWNED
    BY EACH REPORTING
    PERSON WITH:
    5    
      SOLE VOTING POWER
      0
    6    
      SHARED VOTING POWER
      6,064,661
    7    
      SOLE DISPOSITIVE POWER
      0
    8    
      SHARED DISPOSITIVE POWER
      6,064,661
    9    
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      6,064,661
    10    
      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      ¨

     

    11

       
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       15.0%
    12    
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       IN
                             

     

     

     

     

    Item 1.

     

     

    (a)

    Name of Issuer

     

        IsoPlexis Corporation

     

      (b) Address of Issuer’s Principal Executive Offices

     

       

    35 NE Industrial Rd

    Branford, CT 06405

     

    Item 2.

     

      (a) Name of Person(s) Filing

     

       

    Spring Mountain Capital G.P., LLC

    SMC Growth Capital II GP, LLC

    SMC Growth Capital Partners II, LP

    SMC Private Equity Holdings GP, LLC

    SMC Private Equity Holdings, LP

    SMC Holdings II G.P., LLC

    SMC Holdings II, LP

    Gregory P. Ho

    John L. Steffens

     

      (b) Address of Principal Business Office or, if none, Residence

     

        650 Madison Avenue, 20th Floor, New York, NY, 10022

     

      (c) Citizenship

     

       

    Spring Mountain Capital G.P., LLC – Delaware

    SMC Growth Capital II GP, LLC – Delaware

    SMC Growth Capital Partners II, LP – Delaware

    SMC Private Equity Holdings GP, LLC – Delaware

    SMC Private Equity Holdings, LP – Delaware

    SMC Holdings II G.P., LLC – Delaware

    SMC Holdings II, LP – Delaware

    Gregory P. Ho – United States

    John L. Steffens – United States

     

      (d) Title of Class of Securities

     

        Common Stock

     

      (e) CUSIP Number

     

        465005106

     

     

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. ¨78c).
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
      (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
      (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     

    Item 4. Ownership.

     

    The securities are directly held by SMC Growth Capital Partners II, LP ("GCII"), SMC Private Equity Holdings, LP ("PEH"), and SMC Holdings II, LP ("Holdings").

     

    SMC Growth Capital II GP, LLC, a Delaware limited liability company ("GCII GP"), is the general partner of GCII. SMC Private Equity Holdings G.P., LLC, a Delaware limited liability company ("PEH GP"), is the general partner of PEH. SMC Holdings II G.P., LLC, a Delaware limited liability company ("Holdings GP"), is the general partner of Holdings.

     

    Spring Mountain Capital G.P., LLC, a Delaware limited liability company ("SMC GP"), is the managing member of GCII GP and PEH GP.

     

    John L. Steffens and Gregory P. Ho each serve as a managing member of SMC GP and Holdings GP.

     

    GCII, PEH, Holdings, GCII GP, SMC GP, PEH GP, Holdings GP, Mr. Ho, and Mr. Steffens, as filers of this statement are collectively referred to herein as the “Group.” The joint filing agreement of the members of the Group is attached as Exhibit 1 to this Schedule 13G.

     

     

     

      

    Item 5. Ownership of Five Percent or Less of a Class

     

    Not applicable.

      

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group

     

    See Item 4 above.

     

    Item 9. Notice of Dissolution of Group

     

    Not applicable.

     

    Item 10.Certification

     

        By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose, or with the effect, of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

    SIGNATURE

      

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

      

    Date:    February 14, 2023

     

      Spring Mountain Capital G.P., LLC
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Growth Capital II GP, LLC
      By: Spring Mountain Capital G.P., LLC
    Managing Member
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member    
       
      SMC Growth Capital Partners II, LP
       
      By: SMC Growth Capital II GP, LLC
        General Partner
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Private Equity Holdings G.P., LLC
       
      By: Spring Mountain Capital G.P., LLC
        Managing Member
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member

     

     

     

     

      SMC Private Equity Holdings, LP
       
      By: SMC Private Equity Holdings G.P., LLC
        General Partner
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Holdings II G.P., LLC
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Holdings II, LP
       
      By: SMC Holdings II G.P., LLC
        General Partner
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      Gregory P. Ho
       
      /s/ Gregory P. Ho
      Gregory P. Ho
       
      John L. Steffens
       
      /s/ John L. Steffens
      John L. Steffens

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

     

     

     

     

    EXHIBIT 1

     

    JOINT FILING AGREEMENT

     

    In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of the Issuer and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings.

      

    Date: February 14, 2023

     

      Spring Mountain Capital G.P., LLC
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Growth Capital II GP, LLC
       
      By: Spring Mountain Capital G.P., LLC
    Managing Member
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member    
       
      SMC Growth Capital Partners II, LP
       
      By: SMC Growth Capital II GP, LLC
        General Partner
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Private Equity Holdings G.P., LLC
       
      By: Spring Mountain Capital G.P., LLC
        Managing Member
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member

     

     

     

     

      SMC Private Equity Holdings, LP
       
      By: SMC Private Equity Holdings G.P., LLC
        General Partner
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Holdings II G.P., LLC
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      SMC Holdings II, LP
       
      By: SMC Holdings II G.P., LLC
        General Partner
       
      By: /s/ Gregory P. Ho
      Name: Gregory P. Ho
      Title: Managing Member
       
      Gregory P. Ho
       
      /s/ Gregory P. Ho
      Gregory P. Ho
       
      John L. Steffens
       
      /s/ John L. Steffens
      John L. Steffens

     

     

     

    Get the next $ISO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ISO

    DatePrice TargetRatingAnalyst
    2/15/2022$17.00 → $12.00Overweight
    Morgan Stanley
    1/27/2022$20.00 → $15.00Outperform
    SVB Leerink
    11/19/2021$24.00Outperform
    Evercore ISI Group
    11/11/2021$17.00 → $20.00Outperform
    SVB Leerink
    11/2/2021$17.00Outperform
    SVB Leerink
    11/2/2021Outperform
    Cowen & Co.
    11/2/2021$16.00Overweight
    Morgan Stanley
    More analyst ratings

    $ISO
    Financials

    Live finance-specific insights

    See more
    • Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

      Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Companies to Host Joint Conference Call and Webcast Today at 5:00 p.m. ET EMERYVILLE, CA and BRANFORD, Conn., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights (NASDAQ:BLI), a life sciences tools company, and IsoPlexis (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire

      12/21/22 4:49:03 PM ET
      $BLI
      $ISO
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
    • Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

      Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Companies to Host Joint Conference Call and Webcast Today at 5:00 p.m. ET EMERYVILLE, Calif. and BRANFORD, Conn., Dec. 21, 2022 /PRNewswire/ -- Berkeley Lights (NASDAQ:BLI), a life sciences tools company, and IsoPlexis (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoP

      12/21/22 4:15:00 PM ET
      $BLI
      $ISO
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
    • IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

      BRANFORD, Conn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will report financial results for the third quarter 2022 before market open on Thursday, November 10, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.isoplexis.com. The webcast will be archived and available for replay after the event. About IsoPlexis IsoPlexis is empowering labs to leverage the ce

      10/19/22 7:00:00 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $ISO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley reiterated coverage on IsoPlexis with a new price target

      Morgan Stanley reiterated coverage of IsoPlexis with a rating of Overweight and set a new price target of $12.00 from $17.00 previously

      2/15/22 10:15:01 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SVB Leerink reiterated coverage on IsoPlexis with a new price target

      SVB Leerink reiterated coverage of IsoPlexis with a rating of Outperform and set a new price target of $15.00 from $20.00 previously

      1/27/22 4:33:30 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Evercore ISI Group initiated coverage on IsoPlexis with a new price target

      Evercore ISI Group initiated coverage of IsoPlexis with a rating of Outperform and set a new price target of $24.00

      11/19/21 7:09:33 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $ISO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

      PhenomeX to begin trading under symbol (NASDAQ:CELL) EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined company has been renamed PhenomeX and its common stock will begin trading on Nasdaq under the ticker symbol "CELL" at market open tomorrow. PhenomeX is positioned to be the leading

      3/21/23 8:02:00 AM ET
      $BLI
      $ISO
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
    • IsoPlexis Reports Preliminary Full Year 2022 Revenue

      BRANFORD, Conn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended December 31, 2022. Total revenue for the full year ended December 31, 2022 is expected to be in the range of $16.6 to $16.8 million, representing a decrease of approximately 3% to 4% compared to $17.3 million for the full year ended December 31, 2021. Fourth quarter results were lower than expected primarily due to the timing of customer orders for instruments and lower consumable sales, as the previously described macroeconomic head

      1/12/23 4:05:00 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

      Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Companies to Host Joint Conference Call and Webcast Today at 5:00 p.m. ET EMERYVILLE, CA and BRANFORD, Conn., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights (NASDAQ:BLI), a life sciences tools company, and IsoPlexis (NASDAQ:ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire

      12/21/22 4:49:03 PM ET
      $BLI
      $ISO
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus

    $ISO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by IsoPlexis Corporation (Amendment)

      SC 13D/A - IsoPlexis Corp (0001615055) (Subject)

      6/15/23 4:15:39 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)

      SC 13G/A - IsoPlexis Corp (0001615055) (Subject)

      2/14/23 4:33:58 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)

      SC 13G/A - IsoPlexis Corp (0001615055) (Subject)

      2/14/23 2:40:05 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $ISO
    SEC Filings

    See more

    $ISO
    Leadership Updates

    Live Leadership Updates

    See more

    $ISO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 15-12G filed by IsoPlexis Corporation

      15-12G - IsoPlexis Corp (0001615055) (Filer)

      3/31/23 8:32:18 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • IsoPlexis Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits

      8-K - IsoPlexis Corp (0001615055) (Filer)

      3/22/23 8:13:01 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form S-8 POS filed by IsoPlexis Corporation

      S-8 POS - IsoPlexis Corp (0001615055) (Filer)

      3/21/23 5:20:43 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • IsoPlexis Appoints Key Financial and Legal Hires from Leading Tools and Omics Companies

      BRANFORD, Conn., Nov. 30, 2021 /PRNewswire/ -- IsoPlexis (NASDAQ: ISO), the leader in functional single-cell proteomics, today announced the appointment of Richard Rew as Senior VP, General Counsel and Secretary; Raj Khakhar as VP of Finance; and Manny Resendes as Global Controller. These three new appointments further strengthen Isoplexis' financial and legal teams. "We are excited to have Mr. Rew, Mr. Khakhar, and Mr. Resendes join our team at IsoPlexis," said Sean Mackay, CEO of IsoPlexis. "These recent hires will strengthen our ability to accelerate our growth trajectory a

      11/30/21 7:00:00 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • IsoPlexis Bolsters Its Global Operational and Product Support Leadership

      BRANFORD, Conn., Nov. 12, 2021 /PRNewswire/ -- IsoPlexis (NASDAQ:ISO), the leader in functional single-cell proteomics, today announced the appointment of two new leadership positions at the company. Michelle Reid, Ph.D. joins IsoPlexis as VP of Service and Support, and Anthony Catalano joins as the Senior VP of Operations. With these appointments, IsoPlexis continues to strengthen its operations and product support teams, providing high need proteomic products with highly customer centric support. Ms. Reid comes to IsoPlexis with over 20 years of experience leading and devel

      11/12/21 7:00:00 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • IsoPlexis Bolsters Its Global Operational and Product Support Leadership

      BRANFORD, Conn., Nov. 12, 2021 /PRNewswire/ -- IsoPlexis (NASDAQ:ISO), the leader in functional single-cell proteomics, today announced the appointment of two new leadership positions at the company. Michelle Reid, Ph.D. joins IsoPlexis as VP of Service and Support, and Anthony Catalano joins as the Senior VP of Operations. With these appointments, IsoPlexis continues to strengthen its operations and product support teams, providing high need proteomic products with highly customer centric support. Ms. Reid comes to IsoPlexis with over 20 years of experience leading and devel

      11/12/21 7:00:00 AM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Khakhar Rajesh T.

      4 - IsoPlexis Corp (0001615055) (Issuer)

      3/21/23 5:04:56 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Myers Jason W.

      4 - IsoPlexis Corp (0001615055) (Issuer)

      3/21/23 4:53:55 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Ho Gregory P.

      4 - IsoPlexis Corp (0001615055) (Issuer)

      3/21/23 4:52:06 PM ET
      $ISO
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care